Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials.

Cancer treatment and research communications - 1 Jan 2022

Sweeney Patrick L, Jang Albert, Halat Shams K, Pal Sumanta K, Barata Pedro C

Abstract excerpt

Papillary renal cell carcinoma (PRCC) is the most common subtype of non-clear cell renal cell carcinoma. PRCC can be subdivided into types 1 and 2 based on histology, each associated with different genetic mutations. The MET gene is commonly altered in type 1 PRCC while multiple alterations are involved in type 2 PRCC. PRCC is an aggressive cancer with a predominance in male and black patients and poor prognosis....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Renal Cell
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Neoplasms

Share to Mutation

Source

Identifiers

PMID: 36162322
DOI: 10.1016/j.ctarc.2022.100639

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials.PMID 36162322Read ↗

Papillary renal cell carcinoma: A review of the current therapeutic landscape.Semantic proximity Read ↗

Recent progress in non-clear cell renal cell carcinoma: biology and therapeutic strategiesSemantic proximity Read ↗

Papillary renal cell carcinoma: current progress and future directions.Semantic proximity Read ↗

Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the LiteratureSemantic proximity Read ↗

Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseasesSemantic proximity Read ↗

Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features.Semantic proximity Read ↗

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Semantic proximity Read ↗

Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome AtlasSemantic proximity Read ↗

Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.Semantic proximity Read ↗

Comprehensive review of chromophobe renal cell carcinomaSemantic proximity Read ↗

Immune-Based and Novel Therapies in Variant Histology Renal Cell CarcinomasSemantic proximity Read ↗

Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.